Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), also known as Helmholtz Munich, is one of Germany’s leading non-university centers for biomedical research.[1] It operates as part of Helmholtz Health, the health research division within the Helmholtz Association, Germany's largest scientific organization. Helmholtz Munich primarily focuses on interdisciplinary research in the fields of environmental and metabolic diseases, spanning the full research spectrum from basic science to applied research. The center employs approximately 2,500 staff members (as of 2024) and is headquartered on a campus in northern Munich, covering an area of over 50 hectares.
Helmholtz Zentrum München German Research Center for Environmental Health | |
Formation | 1960 |
---|---|
Legal status | GmbH |
Location |
|
CEO | Prof. Dr. med. h.c. Matthias H. Tschöp |
Administrative Managing Director | Dr. Michael Frieser |
Staff | 2515 (in 2024) |
Website | www |
Management
editProf. Dr. med. Dr. h.c. Matthias H. Tschöp has been the Scientific Director and chief executive officer of the Center since 2018. In 2024, Dr. Michael Frieser joined the center and is now Administrative Managing Director.
Campus
editThe main campus is located in Neuherberg, a district of Oberschleißheim, right outside of Munich’s city borders. The campus has a size of 52.3 hectares. In addition, the center maintains research facilities inside the city area of Munich, Augsburg, Tübingen, Hanover, Dresden and Leipzig.[2]
Legal form
editHelmholtz Zentrum München is a limited liability company according to German law and is financed by a ratio of 90:10 by its two shareholders, the Federal Government and the Free State of Bavaria.
Its research focuses primarily on environmental and metabolic diseases, particularly diabetes, -obesity, allergies, and chronic lung diseases. Other centers include:
- Helmholtz Diabetes Center
- Environmental Health Center
- Molecular Targets and Therapeutics Center
- Stem Cell Center
- Bioengineering Center
- Computational Health Center
Helmholtz Pioneer Campus (HPC)
editThe Helmholtz Pioneer Campus is an interdisciplinary research platform where innovative approaches from the interface between biomedical research, engineering and artificial intelligence are developed. The aim of the Pioneer Campus is to develop solutions for health challenges by combining basic research and applied science and to accelerate the transfer of research results into clinical applications.[4]
Translational and clinical projects
editTranslational research approaches at the center are developed in cooperation with clinical partners:[5]
- Diabetes Study Center
- Comprehensive Pneumology Center
- Center of Allergy and Environment
Career development
editThe center has one Helmholtz Graduate School (HELENA) in cooperation with the Ludwig Maximilian University of Munich (LMU) and the Technical University Munich (TUM), and four Helmholtz Research Schools. The schools offer doctoral students in-depth research in the fields of diabetes, lung and radiation research, epigenetics and data science:
- Helmholtz Graduate School Environmental Health (HELENA)
- International Helmholtz Research School for Diabetes
- EpiCrossBorders: International Helmholtz-Edinburgh Research School for Epigenetics
- CPC-Research School Lung Biology and Disease
- Munich School for Data Science
References
edit- ^ Suhre, Karsten (2012-06-15). Genetics Meets Metabolomics: from Experiment to Systems Biology. Springer Science & Business Media. ISBN 978-1-4614-1689-0.
- ^ "Locations".
- ^ "helmholtz zentrum münchen - Google Search". www.google.com. Retrieved 2024-11-19.
- ^ "Home". pioneercampus.org.
- ^ "Innovation & Translation".